(1) Whitaker R. Mad In America: Bad Science, Bad Medicine, And The Enduring Mistreatment Of The Mentally Ill. Cambridge, MA: Perseus Publishing,...
(2) Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg, AJ, et al. A Comparison of Nefazodone, the Cognitive Behavioral-Analysis...
(3) Angell M. Is Academic Medicine for Sale? N Engl J Med 2000; 342:1516-1518
(4) Angell M. The Truth About the Drug Companies: How They Deceive Us and What to Do About. New York: Random
House, 2004
(5) Angell M. The Epidemic of Mental Illness: Why?. New York Review of Books, 23 de junio de 2011 [Accesible en: http://www.nybooks.com/articles/archives/2011/jun/23/epidemic-mental-illness-why/?pagination=false;...
(6) Angell M. The illusions of Psychiatry. New York Review of Books, 14 de Julio de 2011 [Accesible en: http://www.nybooks.
com/articles/archives/2011/jul/14/illusionsof-psychiatry/?pagination=false;...
(7) Kramer PD. In Defense of Antidepressants. New York Times, 9 de Julio de 2011 [Accesible en: http://
www.nytimes.com/2011/07/10/opinion/sunday/10antidepressants.html?_r=2&pagewanted=all;...
(8) Hyman SE, Nestler EJ. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996; 153: 151-62.
(9) Seikkula J. Open dialogues with good and poor outcomes for psychotic crises: examples from families with violence. J
Marital Fam Ther...
(10) Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up...
(11) Harrow M, Jobe TH. Factors Involved in Outcome and Recovery in Schizophrenia Patients Not on Antipsychotic Medications: A 15-Year Multifollow-Up...
(12) Remington G, Seeman P, Feingold A, Mann S, Shammi C, Kapur S. “Extended” antipsychotic dosing in the maintenance
treatment of schizophrenia:...
